Adamis Pharmaceuticals | Cassa E Equivalenti



Cash And Equivalent Cambiamento Data
Adma Biologics USD 103.15M 16.44M 2024-12
Cipla INR 8B 1.22B 2025-03
Clal Biotechnology ILS 5.73M 1.71M 2023-12
Compugen USD 18.23M 11.01M 2024-12
CSL 1.52B 133M 2024-12
GlaxoSmithKline GBP 4.46B 594M 2025-03
Glaxosmithkline GBP 3.87B 678M 2024-12
Grifols EUR 979.78M 334.84M 2024-12
Merck USD 8.63B 4.61B 2025-03
Pfizer USD 1.43B 387M 2025-03
RedHill Biopharma USD 7.28M 3K 2024-06



Adamis Pharmaceuticals Cassa E Equivalenti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.